Nectar bags major deal form GSK in regulated markets
Tuesday, November 17, 2009 15:30 IST Our Bureau, Mumbai
Nectar Life sciences Ltd, a US$ 200 million organisation, with a strong presence in anti-bacterial segment of global pharma, particularly Cephalosporins, has initiated a long term supply of its innovation molecule bulk drug (API)
